Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCG | P01275 | 1/20 | 0.53 |
| ▸ | GCGR | P47871 | 6/20 | 0.49 |
| ▸ | GIPR | P48546 | 1/20 | 0.49 |
| ▸ | NR1H4 | Q96RI1 | 3/20 | 0.48 |
| ▸ | ESRRG | P62508 | 3/20 | 0.48 |
| ▸ | NPC1 | O15118 | 3/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | CASP3 | P42574 | 1/20 | 0.48 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.48 |
| ▸ | ADCY6 | O43306 | 3/20 | 0.47 |
| ▸ | ADCY3 | O60266 | 3/20 | 0.47 |
| ▸ | ADCY9 | O60503 | 3/20 | 0.47 |
| ▸ | ADCY5 | O95622 | 3/20 | 0.47 |
| ▸ | ADCY8 | P40145 | 3/20 | 0.47 |
| ▸ | ADCY7 | P51828 | 3/20 | 0.47 |
| ▸ | ADCY2 | Q08462 | 3/20 | 0.47 |
| ▸ | ADCY1 | Q08828 | 3/20 | 0.47 |
| ▸ | ADCY4 | Q8NFM4 | 3/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2653579 | 0.94 | NPC1 (0.50) | GCGGCGRGIPRNR1H4ESRRG | |
| SCHEMBL2654032 | 0.92 | ESRRG (0.47) | GCGGCGRGIPRNR1H4ESRRG | |
| SCHEMBL2654456 | 0.90 | GCG (0.50) | GCGGCGRGIPRCYP4F2CYP4A11 | |
| SCHEMBL2655011 | 0.90 | GCG (0.50) | GCGGCGRGIPRCYP4F2CYP4A11 | |
| SCHEMBL2654793 | 0.90 | GCG (0.50) | GCGGCGRGIPRCYP4F2CYP4A11 | |
| SCHEMBL2657400 | 0.89 | GCG (0.50) | GCGGCGRGIPRNR1H4ESRRG | |
| SCHEMBL2654702 | 0.89 | NPC1 (0.58) | GCGRNR1H4ESRRGNPC1RAB9A | |
| SCHEMBL2656581 | 0.88 | NPC1 (0.57) | GCGRNR1H4ESRRGNPC1RAB9A | |
| SCHEMBL2655220 | 0.88 | NPC1 (0.57) | GCGRNR1H4ESRRGNPC1RAB9A | |
| SCHEMBL2655124 | 0.88 | NPC1 (0.57) | GCGRNR1H4ESRRGNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1758853-A1 | GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES | ELI LILLY AND COMPANY (US) | 2007-03-07 | — | — | EP | claimed |
| WO-2005123668-A1 | GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES | ELI LILLY AND COMPANY (US) | 2005-12-29 | — | — | WO | claimed |
| EP-1758853-A1 | GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES | ELI LILLY AND COMPANY (US) | 2007-03-07 | — | — | EP | disclosed |
| WO-2005123668-A1 | GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES | ELI LILLY AND COMPANY (US) | 2005-12-29 | — | — | WO | disclosed |